Analyzing Life Sciences VC Activity's Main Hot Spots
In Bridge Bank's latest Markets to Watch series, the surge in venture investment across life sciences in the key metro areas of the Bay Area, Boston and Southern California are analyzed in depth. Building on the steady technical advances of the 21st century so far, multiple segments of life sciences are now proffering significant breakthroughs, from the suddenly omnipresent mRNA-based therapies to CRISPR-derived tests. The space is thriving, in short, as the report finds.
Life Sciences Group
Bridge Bank’s Life Sciences Group, a national banking group within Western Alliance Bank, Member FDIC, delivers tailored financial lending solutions across all life sciences verticals to innovators nationwide as they bring their products from lab to market, backed by outstanding service. Experienced, knowledgeable relationship managers understand the unique challenges and opportunities life science companies face in all stages of their growth trajectory and provide sophisticated products and services that make a difference. Bridge Bank is part of Western Alliance Bancorporation, which has more than $80 billion in assets. Major accolades include being ranked as a top U.S. bank in 2024 by American Banker and Bank Director.
